News

Sidus Space stock plunges after pricing public offering
Investing.com -- Sidus Space Inc (NASDAQ: SIDU) shares tumbled 46.5% in pre-market trading after the space and defense technology company announced the pricing of a public offering that will ...
Gold: Are Bulls Losing Grip as Risk-On Trade, Tariff Deals Shift Flows?
Gold Spot US Dollar, Microsoft Corporation, Apple Inc, Amazon.com Inc. Read 's Market Analysis on Investing.com ...
Romania expects small growth hit from new US trade deal
"Economic growth in the euro zone will be affected, with estimates from international institutions showing a possible reduction in the growth rate by 0.3%-0.4%, which would mean a reduction in ...
Stereotaxis stock soars after FDA clearance for robotic mapping catheter
Investing.com -- Stereotaxis (NYSE: STXS) stock surged 12% after the company received U.S. Food and Drug Administration (FDA) 510 (k) clearance for its MAGiC Sweep catheter, the world’s first ...
Barclays downgrades Rémy Cointreau to “underweight” amid cognac sector struggles
Investing.com -- Barclays downgraded Rémy Cointreau (EPA: RCOP) to “underweight” from “equal weight,” citing the company’s ...
Nvidia’s H20 stockpile won’t meet accelerating China demand: Jefferies
Investing.com -- Nvidia’s inventory of H20 AI chips is unlikely to satisfy surging demand in China following a temporary lift of U.S. export restrictions, according to Jefferies. The firm estimates ...
CervoMed stock soars after positive dementia drug trial data
Investing.com -- CervoMed Inc. (NASDAQ: CRVO) stock rose 30% after the company reported positive 32-week data from its RewinD-LB trial showing that its experimental drug neflamapimod significantly ...
Tariff-fueled inflation seen weighing on lower income spending - Morgan Stanley
Investing.com - Elevated U.S. tariffs could spark inflation that will slow spending more for lower income cohorts than those ...
Extended Elinzanetant FDA review seen as ’a small negative’ for Bayer
Barclays views the development as “a small negative for Bayer,” though analysts remain positive on the drug’s approval prospects. The bank said the delay likely won’t affect Bayer’s 2025 sales ...
Walmart says tariffs are already driving prices higher
Investing.com -- Walmart has begun raising prices on a range of goods as new tariffs take effect, but expects to gain market ...
Enterprise Products Partners beats on earnings, misses on revenue
HOUSTON - Enterprise Products Partners L.P. (NYSE: EPD) reported second quarter earnings of $0.66 per unit, slightly above analyst expectations of $0.65, while revenue fell short at $11.36 billion ...
UBS initiates “neutral” rating on Kingfisher, cites U.K. strength, French uncertai
Investing.com -- UBS has initiated coverage on Kingfisher (LON: KGF) Plc with a "neutral" rating and a price target of 280p, in a note dated Monday. This decision reflects a balanced view of ...